N Srikanth Selected Research

Ayush 64

4/2022	AYUSH- 64: A potential therapeutic agent in COVID-19.
1/2022	Author's reply to correspondence 'influenza like illness related clinical trial on AYUSH-64 requires cautious interpretation'.
1/2022	In silico evaluation of the compounds of the ayurvedic drug, AYUSH-64, for the action against the SARS-CoV-2 main protease.
1/2022	AYUSH 64, a polyherbal Ayurvedic formulation in Influenza-like illness - Results of a pilot study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

N Srikanth Research Topics

Disease

3	COVID-19 04/2022 - 04/2021
2	Human Influenza (Influenza) 01/2022 - 01/2022
1	Fever (Fevers) 01/2022
1	Virus Diseases (Viral Diseases) 01/2022
1	Severe Acute Respiratory Syndrome 01/2022
1	Cough 01/2022

Drug/Important Bio-Agent (IBA)

4	Ayush 64IBA 04/2022 - 01/2022
1	OxidesIBA 01/2022
1	Peptide Hydrolases (Proteases)FDA Link 01/2022
1	VaccinesIBA 01/2022
1	akuammicineIBA 01/2022
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2022

Therapy/Procedure

1	Patient Isolation 04/2022
1	Traditional Medicine (Folk Remedies) 04/2021